Impact of substance P receptor antagonism on the serotonin and norepinephrine systems: relevance to the antidepressant/anxiolytic response

AUTOR(ES)

Blier, Pierre

RESUMO

Substance P (neurokinin-1 [NK1]) receptor antagonists appear to be effective antidepressant and anxiolytic agents, as indicated in 3 double-blind clinical trials. In laboratory animals, they promptly attenuate the responsiveness of serotonin (5-hydroxytryptamine [5-HT]) and norepinephrine (NE) neurons to agonists of their cell-body autoreceptors, as is the case for some antidepressant drugs that are currently in clinical use. Long-term, but not subacute, antagonism of NK1 receptors in rats increases 5-HT transmission in the hippocampus, a property common to all antidepressant treatments tested thus far. This enhancement seems to be mediated by a time-dependent increase in the firing rate of 5-HT neurons. Mice with the NK1 receptor deleted from their genetic code also have an increased firing rate of 5-HT neurons. Taken together, these observations strongly suggest that NK1 antagonists could become a new class of antidepressant and anxiolytic agents.

Documentos Relacionados

• Norepinephrine-deficient mice lack responses to antidepressant drugs, including selective serotonin reuptake inhibitors
• Interactions between central monoaminergic systems: dopamine-serotonin.
• Antibiotic tissue penetration and its relevance: impact of tissue penetration on infection response.
• Serotonin and substance P coexist in neurons of the rat's central nervous system
• Selective inhibition of the carotid body sensory response to hypoxia by the substance P receptor antagonist CP-96,345.